
Passage Bio, Inc.
USD5.97
+0.07 (+1.27%)
CEO
William Chou
IPO Date
2020-02-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.82
Prev. Close
$5.89
Day Low
$5.81
Day High
$5.98
52W Low
$3.94
52W High
$20.00
Market Cap
$0.02B
Volume
0.03M
| 21 Apr 2026 |
| TD Cowen |
| Buy |
| Hold |
| downgrade |
| 4 Mar 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 12 Nov 2025 | Chardan Capital | Buy | Buy | maintain |
| 14 Aug 2025 | Canaccord Genuity | Buy | Buy | maintain |
| 14 Aug 2025 | Guggenheim | Buy | Buy | maintain |
| 13 Aug 2025 | Wedbush | Outperform | Outperform | maintain |
| 24 Jun 2025 | Chardan Capital | Buy | Buy | maintain |